Hemoglobin Test

Your hemoglobin level is one of the most direct measurements of how well your blood can do its primary job: move oxygen from your lungs to every cell that needs it. When this number drifts too low, your tissues starve for oxygen quietly, sometimes for months, causing fatigue, brain fog, and exercise intolerance long before you look or feel obviously sick. When it climbs too high, your blood thickens, and the risk of heart attack and stroke rises sharply.

What makes hemoglobin particularly valuable for anyone tracking their health is the U-shaped relationship between this number and mortality. Both the low end and the high end carry real risk, and the sweet spot in the middle differs by sex. Knowing where you sit on that curve, and watching how your number trends over time, gives you information that no symptom check or general wellness panel can replicate.

What Hemoglobin Is and How It Works

Hemoglobin (Hb) is a large protein made up of four interlocking chains, each carrying an iron-containing structure called a heme group. Each heme group can grab one oxygen molecule, so a single hemoglobin protein carries up to four oxygen molecules at once. Adults produce hemoglobin in the bone marrow as red blood cells mature, and each red blood cell is packed with roughly 270 million hemoglobin molecules.

The protein has a built-in switching mechanism: when it reaches oxygen-rich tissue in the lungs, it snaps into a shape that grabs oxygen tightly. When it arrives at tissues that are low on oxygen, it relaxes into a different shape and releases its cargo. This is why hemoglobin works so efficiently as a delivery system. Your hemoglobin level, measured in grams per deciliter (g/dL), tells you how much of this delivery capacity your blood has at any given time.

Heart Disease and Cardiovascular Mortality

Large studies consistently show that hemoglobin levels at both extremes increase cardiovascular risk. A study of nearly 1.54 million blood donors in Sweden and Denmark found that men with hemoglobin at or above 17.5 g/dL were about 3.5 times as likely to have a heart attack and about 2.4 times as likely to have a stroke caused by a blood clot (ischemic stroke) compared to men in the normal range. Women with hemoglobin at or above 16.0 g/dL faced similarly elevated risk, roughly 3.2 times the rate of heart attack.

The low end is equally dangerous. In the REGARDS study of over 16,000 adults aged 45 and older, white participants in the lowest hemoglobin group were about 2.3 times as likely to develop coronary heart disease compared to those in the middle range. Black participants in the lowest group had about 1.7 times higher risk. A 25-year Japanese study of over 7,200 adults confirmed the U-shape: both the lowest and highest hemoglobin groups had roughly 40% to 49% higher cardiovascular mortality.

What this means for you: if your hemoglobin is persistently at the high or low end of the reference range, the cardiovascular signal is real and worth investigating, even if you feel fine.

All-Cause Mortality: The Sweet Spot

The relationship between hemoglobin and overall death risk follows the same U- or J-shaped curve. A Korean cohort study of 292,194 adults tracked over 8 years found that people whose hemoglobin returned to the normal range after being anemic had about 33% lower mortality than those who stayed anemic. But hemoglobin rising above the normal range increased mortality risk by about 39%.

A Taipei study of over 77,000 adults aged 65 and older identified the mortality sweet spots: 15.0 to 15.9 g/dL for men, and 13.0 to 13.9 g/dL for women. Anemia (defined by WHO thresholds) roughly doubled mortality risk in older men and raised it about 63% in older women. A Finnish study of nearly 1,000 adults followed for over 20 years found that the highest hemoglobin quartile carried about 48% higher total mortality and about double the cardiovascular mortality compared to lower quartiles.

Stroke Risk

The REGARDS stroke study of over 30,000 participants found sex-dependent effects. Women in both the lowest and highest hemoglobin quartiles were about 59% more likely to have a stroke compared to the second quartile. Men did not show a statistically significant association in this study.

Cancer and Mortality in Older Adults

The Women's Health Initiative, following over 160,000 postmenopausal women for a median of 16 years, linked both low and high hemoglobin to increased total mortality. Low hemoglobin was strongly associated with coronary heart disease mortality and cancer mortality. High hemoglobin was associated with total mortality, though the link to cancer death was weaker.

In Italian elderly cohorts totaling over 6,300 adults, even mild anemia (hemoglobin between 10.0 and 11.9 g/dL in women, or 10.0 and 12.9 g/dL in men) increased mortality by about 28% to 35% depending on age group. There was a dose-response pattern: the more severe the anemia, the higher the mortality.

Reference Ranges

Hemoglobin values differ meaningfully between sexes and shift across the lifespan. The ranges below draw from both WHO thresholds and a major 2024 international analysis that derived data-driven cutoffs from healthy reference populations across the US, England, Australia, and China. That analysis found no evidence supporting ethnicity-specific adjustments.

These tiers are drawn from published research. Your lab may use different testing methods and cutpoints. Compare your results within the same lab over time for the most meaningful trend. The 2024 Lancet Haematology analysis proposed a data-driven anemia threshold of 13.5 g/dL for men (slightly higher than the longstanding WHO cutoff of 13.0) and 12.0 g/dL for women, reinforcing that the WHO thresholds may undercount anemia in men.

Tracking Your Trend

A single hemoglobin reading is a snapshot. A trend is a story. Hemoglobin has a low within-person biological variation of about 2.8% to 4.0%, which means the number is quite stable in healthy people over weeks and months. This stability is actually an advantage: when hemoglobin does shift, it is more likely to represent a real change in your body rather than random noise.

The reference change value, the minimum difference between two readings that represents a true biological shift rather than normal fluctuation, is about 8% to 11%. For a typical hemoglobin around 14.0 g/dL, that translates to roughly 1.0 to 1.5 g/dL. If your hemoglobin drops by more than that between two tests drawn under the same conditions, something has likely changed.

Get a baseline reading, then retest in 3 to 6 months if you are making dietary changes or starting supplementation. After that, annual monitoring is a reasonable cadence for most people. If you are managing a condition that affects red blood cells (kidney disease, chronic inflammation, heavy menstrual periods), more frequent testing every 1 to 3 months gives you a tighter picture. Always compare results from the same lab, drawn at roughly the same time of day, to minimize variation from factors unrelated to your health.

When Results Can Be Misleading

Hemoglobin has a natural daily rhythm. Levels are highest in the morning and drift lower through the day, with a swing of about 0.5 g/dL. One study found that men's mean hemoglobin was about 3.4 g/L higher at 11 AM than at 7 PM, with a similar pattern in women. If you test in the morning one time and in the evening the next, the apparent change may be entirely from timing, not biology.

Exercise temporarily raises hemoglobin by about 0.46 g/dL during activity because plasma water shifts out of the blood vessels, concentrating whatever remains. This effect disappears within about 2 hours of stopping. Dehydration produces a similar artifact: your hemoglobin looks higher simply because there is less water in the blood, not because you have more red blood cells.

Acute illness or surgery suppresses hemoglobin through inflammation. After surgery, hemoglobin typically drifts down 1.3 to 2.5 g/dL over the first 3 to 4 days, driven by fluid shifts, blood loss, and an inflammatory response that locks iron away from new red blood cell production. This postoperative dip often looks like iron deficiency anemia on labs, but iron supplementation is usually ineffective in the immediate post-surgical period because the issue is inflammation blocking iron use, not true iron depletion. Wait at least 2 to 4 weeks after surgery or acute illness before interpreting hemoglobin results as a reflection of your baseline.

Several common medications shift hemoglobin without causing the conditions the test is designed to detect. Metformin lowers hemoglobin by about 0.5 to 1.0 g/dL within the first 6 months, independent of vitamin B12 changes. ACE inhibitors produce a dose-dependent drop, with each 10 mg increment of enalapril increasing the odds of anemia about 1.45-fold. SGLT2 inhibitors (used for diabetes and heart failure) raise hemoglobin in 2% to 22% of users by stimulating red blood cell production. If you are taking any of these, factor the medication into your interpretation before assuming a change means something new is wrong.